Health Trials

Mitral Valve Regurgitation (Degenerative or Functional)

2

Review clinical trials related to Mitral Valve Regurgitation (Degenerative or Functional). Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

TVMR With the INNOVALVE System Trial - Early Feasibility Study

Study to evaluate the safety and performance of the INNOVALVE system

Participants needed: 65
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Edwards LifesciencesUpdated: May 28, 2026Locations: 20
Eligibility criteria

Clinically significant, symptomatic mitral regurgitation [+2]

Unsuitable anatomy [+2]

Read more
Status: Recruiting

Mitral Annular Repair With the CathHELIX™ Transcatheter System in Subjects With FMR

Patients with functional mitral regurgitation classified as moderate to severe (3+) or severe (4+) that are symptomatic (NYHA Class II-IV) will be evaluated for treatment using the CathHELIX Transcatheter Mitral Annuloplasty System.

Participants needed: 5
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: HVR Cardio OyUpdated: Sep 23, 2025Locations: 2
Eligibility criteria

Moderate to severe (3+) or severe (4+) functional mitral regurgitation [+2]

Oxygen dependent for COPD [+5]

Read more